Patents by Inventor Scott Eldor Pflughoeft

Scott Eldor Pflughoeft has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9676942
    Abstract: A process of formulating a curable thermoset resin formulation is provided that includes reacting a natural cellulosic filler with at least one of: a silsesquioxane, a isocyanate, a base, or an organic acid to form a reduced hydrophilicity filler. By intermixing the resulting reduced hydrophilicity filler with a thermoset cross linkable polymeric resin, a curable thermoset resin formulation is formed that has superior properties to conventional formulations in terms of density and environmental impact. The formulation properties in terms of strength of the cured article are improved relative to untreated natural fillers. The treatment is advantageous relative to plasma treatment. An article is also provided produced upon cure of the formulation.
    Type: Grant
    Filed: July 19, 2012
    Date of Patent: June 13, 2017
    Assignee: CONTINENTAL STRUCTURAL PLASTICS, INC.
    Inventors: Probir Kumar Guha, Michael J. Siwajek, Michael Joseph Hiltunen, Scott Eldor Pflughoeft, Swati Neogi
  • Publication number: 20140329964
    Abstract: A process of formulating a curable thermoset resin formulation is provided that includes reacting a natural cellulosic filler with at least one of: a silsesquioxane, a isocyanate, a base, or an organic acid to form a reduced hydrophilicity filler. By intermixing the resulting reduced hydrophilicity filler with a thermoset cross linkable polymeric resin, a curable thermoset resin formulation is formed that has superior properties to conventional formulations in terms of density and environmental impact. The formulation properties in terms of strength of the cured article are improved relative to untreated natural fillers. The treatment is advantageous relative to plasma treatment. An article is also provided produced upon cure of the formulation.
    Type: Application
    Filed: July 19, 2012
    Publication date: November 6, 2014
    Inventors: Probir Kumar Guha, Michael J. Siwajek, Michael Joseph Hiltunen, Scott Eldor Pflughoeft, Swati Neogi